Providers/Grant Support
This activity is supported by educational funding provided by Amgen.
Credits Available
- Physicians — 1.5 AMA PRA Category 1 CreditTM
- Nurses — 1.5 ANCC contact hour
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity is designed to meet the educational needs of rheumatologists and their associated advanced practice providers (APPs, e.g., nurse practitioners and physician assistants) involved in the evaluation and management of patients with IgG4-RD.
Program Overview
In this case-based presentation, faculty will assess the severity of IgG4-related disease (IgG4-RD) by exploring its varied clinical manifestations. The session will highlight the latest diagnostic and classification criteria to enable earlier identification of IgG4-RD. Additionally, faculty will review clinical trial data on current and emerging therapies to guide evidence-based treatment decisions.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Evaluate the severity of IgG4-related disease (IgG4-RD) by considering its diverse clinical presentations
- Apply the latest diagnostic and classification criteria for IgG4-RD to accurately assess disease activity and enhance diagnostic precision
- Analyze clinical trial data on current and emerging therapies to inform treatment decisions for IgG4-RD
Faculty
Matthew C. Baker, MD, MS
Associate Division Chief
Assistant Professor of Medicine
Division of Immunology and Rheumatology
Stanford University
Stanford, California
John H. Stone, MD, MPH
Professor of Medicine
Harvard Medical School
The Edward A. Fox Chair in Medicine
Massachusetts General Hospital
Executive Chairman, IgG4ward! Foundation
Boston, Massachusetts
Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
Med Learning Group designates this activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nurses (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
ACCME Innovation Partner
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
ACCME Innovation Partner Disclaimer
Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
Disclosures of Conflict of Interest
Instructions for Participation and Credit
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
